---
id: "bt-entra-signin-investigation"
title: "Entra sign-in and consent investigation"
kind: "workflow"
cve: null
related-cves: null
cve-note: null
severity: "info"
cvss: 0
severity-basis: "cvss"
severity-note: null
product: "Microsoft Entra ID"
versions: "-"
ports: "Any"
keywords: "Microsoft Entra ID, Entra sign-in and consent investigation, blue-team, evidence, authorized assessment"
entry: "Entra sign-in and consent investigation"
verified: false
verified-on: null
verification-evidence: null
source-url: "https://learn.microsoft.com/en-us/entra/identity/monitoring-health/concept-sign-ins"
vendor-advisory: null
cwe: null
patch-date: null
sources: "Project-authored operational checklist with primary-source background; documentation URL availability checked during the 2026-11-13 expansion. No lab or production validation is claimed."
kev: null
kev-date: null
kev-source: null
epss: null
epss-percentile: null
epss-date: null
epss-source: null
enrichment-updated: null
---

# Entra sign-in and consent investigation

## Objective and scope

Investigate and improve the stated control with validated telemetry, explicit ownership and reversible changes. This is a workflow, not a CVE or a severity-scored finding.

## Preconditions

- Written scope or an incident-response mandate, a named system owner and agreed stop/escalation conditions.
- Approved test identities/data and a private evidence location with a defined retention period.
- Current product documentation and visibility into the control being assessed.

## Procedure

1. Confirm access to the relevant sign-in and audit logs, licensing constraints and retention.
2. Correlate user/service-principal sign-ins with authentication details, conditional-access decisions and device/session context.
3. Review recent consent grants, application credentials, role changes and actor/source relationships.
4. Validate unusual activity with the user and tenant owner before revoking sessions or changing policies.

## Evidence and acceptance criteria

Sign-in/audit event IDs, application IDs, policy results and a timeline without raw tokens. Record expected behavior before the test and the actual outcome afterward; mark missing evidence as unknown.

## False positives and limits

IP geolocation, VPNs, mobile networks and synchronization jobs can produce misleading location or frequency anomalies. Do not change the record's laboratory-verification fields merely because a checklist was read or an inventory match was found.

## Handoff and cleanup

Agree session, credential and application-grant containment separately; each can have different persistence semantics. Remove synthetic accounts, objects, markers and temporary permissions introduced by the exercise, or record an owner-approved retention exception. Keep incident evidence under the agreed retention policy.

## References

- [Primary-source background](https://learn.microsoft.com/en-us/entra/identity/monitoring-health/concept-sign-ins). This project-authored checklist is not a verbatim vendor procedure and must be adapted to the deployed product and authorization.
